Itching, or pruritus, is a common symptom that affects millions of people around the world. It can range from a mild annoyance to a debilitating condition. Although it is not life-threatening, it can cause significant physical and psychological distress. The International Classification of Diseases, 10th revision (ICD-10) classifies itching as a symptom, which can be caused by a variety of underlying conditions. This article will explore the causes and treatments of itching, as classified by the ICD-10.
The ICD-10 classifies itching as a symptom, which can be caused by a variety of underlying conditions. These conditions can be divided into three main categories: skin diseases, systemic diseases, and external causes.
Skin diseases are the most common cause of itching. These include conditions such as eczema, psoriasis, scabies, and contact dermatitis. Eczema is a chronic inflammatory condition of the skin that causes itching, redness, and dryness. Psoriasis is a chronic skin condition characterized by thick, scaly patches of skin. Scabies is an infestation of the skin by mites, which causes intense itching. Contact dermatitis is an allergic reaction to certain substances that come into contact with the skin, such as certain soaps, detergents, and cosmetics.
Systemic diseases are conditions that affect the entire body, rather than just the skin. These can cause itching due to the release of certain substances in the body. Examples of systemic diseases that can cause itching include kidney disease, liver disease, and certain types of cancer. Kidney disease can cause itching due to the buildup of waste products in the body. Liver disease can cause itching due to the accumulation of bile acids in the skin. Certain types of cancer can cause itching due to the release of certain hormones or proteins.
External causes of itching include insect bites, sunburn, and certain medications. Insect bites can cause itching due to an allergic reaction to the saliva of the insect. Sunburn can cause itching due to the inflammation of the skin. Certain medications, such as antibiotics and nonsteroidal anti-inflammatory drugs, can cause itching as a side effect.
The treatment of itching depends on the underlying cause. For skin diseases, treatments may include topical medications, such as corticosteroids, or light therapy. For systemic diseases, treatments may include medications to treat the underlying condition, as well as medications to help reduce the itching. For external causes, treatments may include topical medications, such as antihistamines, to reduce the itching.
Itching is a common symptom that can be caused by a variety of underlying conditions. The International Classification of Diseases, 10th revision (ICD-10) classifies itching as a symptom, which can be caused by skin diseases, systemic diseases, and external causes. Treatment of itching depends on the underlying cause, and may include topical medications, medications to treat the underlying condition, or light therapy. It is important to seek medical advice if itching persists, as it can cause significant physical and psychological distress.
1.
GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium
2.
The main subject is associated with suicide in the United States.
3.
Alkem introduces cetuximab under the trade name Cetuxa in India.
4.
Firefighters who eat better can combat cancer.
5.
How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace
1.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
2.
Progressive Insights in Hematology in the Digital Era
3.
Clinical Decision-Making in Oligometastatic Cancer: A Case-Based Perspective
4.
Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources
5.
The Rise of Immunotherapy: New Advances in Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
2.
Blood Clotting Disorders Explained
3.
Sickle Cell Disease Explained
4.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation